1 |
WaheedaSureshbabu, CNMT, PET; and Osama Mawlawi, PhD. PET/CT Imaging Artifacts. J Nucl Med Technol. 2005;33:156-161.
|
2 |
김영설, 김덕윤. PET의 달인 되기. 군자 출판사. 2007. p39-41.
|
3 |
Corrigan JA, Schleyer PJ, Cook GJ. Pitfalls and Artifacts in the Use of PET/CT in Oncology Imaging.SeminNucl Med. 2015.02; volume 45, Issue 6 481-499.
|
4 |
Harnish R, Prevrhal S, Alavi A, Zaidi H, Lang TF. The effect of metal artiact reduction on CT-based attenuation correction for PET imaging in the vicinity of metallic hip implants: a phantom study. AnnNucl Med. 2014 Jul; 28(6):540-50.
|
5 |
Bockisch A, Beyer T, Antoch G, Freudenberg LS, Kuhl H, Debatin JF, Muller SP.Positron emission tomography/computed tomography-imaging protocols, artifacts, and pitfalls. Mol Imaging Biol. 2004 Jul-Aug; 6(4):188-99.
DOI
|
6 |
Lodge MA, Mhlanga JC, Cho SY, Wahl RL. Effect of patient arm motion in whole-body PET/CT.J Nucl Med. 2011 Dec; 52(12):1891-7.
DOI
|
7 |
Matthew R. Acker, BHSc; and Steven C. Burrell, MD. Utility of -FDG PET in Evaluating Cancers of Lung. J Nucl Med Technol2005; 33:69-74.
|
8 |
Callahan J, Binns D, Deller T, Hicks RJ. Scatter limitation to correct for arm movement in PET/CT. ClinNucl Med. 2012 Aug; 37(8):786-7.
|
9 |
Miwa K, Umeda T, Murata T, Wagatsuma K, Miyaji N, Terauchi T, Koizumi M, Sasaki M.Evaluation of scatter limitation correction: a new method of correcting photopenic artifacts caused by patient motion during whole-body PET/CT imaging. Nucl Med Commun. 2016 Feb; 37(2):147-54.
DOI
|
10 |
반영각 외 8 명. PETCT 검사에서 움직임에 의한 인공물의 산란 제한 보정법 적용 영상 평가. KJNMT 2012. 16권, 2호; 44-48.
|
11 |
Dominique Delbeke, R. Edward Coleman, Milton J. Guiberteau, Manuel L. Brown, Henry D. Royal, Barry A. Siegel, David W. Townsend, Lincoln L. Berland, J. Anthony Parker, Karl Hubner, Michael G. Stabin, George Zubal, Marc Kachelriess, Valerie Cronin, and Scott Holbrook. Procedure Guideline for Tumor Imaging with -FDG PET/CT 1.0*. http://www.snm.org/guidelines.
|
12 |
Nancy Paquet, MD; Adelin Albert, PhD; Jacqueline Foidart, MD, PhD; and Roland Hustinx, MD, PhD. Within-Patient Variability of -FDG : Standardized Uptake Values in Normal Tissues. J Nucl Med 2004; 45:784-788.
|
13 |
Furuta A, Onishi H, Kangai Y, Shigehiro Y, Kawasaki. Effect of Scatter Limitation Correction with Misregistration between Computed Tomography and Positron Emission Tomography on Scatter Correction: A Physical Phantom Study. JSRT. 2017_73.3.185.
|
14 |
Corneline J. Hoekstra, MD; Otto S. Hoekstra, MD, PhD; Sigrid G. Stroobants, MD;JohanVansteenkiste, MD, PhD; Johan Nuyts, PhD; Egbert F. Smit, MD, PhD; Maarten Boers, MD, PhD;Jos W.R. Twisk, PhD; and Adriaan A. Lammertsma, PhD. Methods to Monitor Response to Chemotherapyin Non-Small Cell Lung Cancer with -FDGPET. J Nucl Med 2002; 43:1304-1309.
|
15 |
Nikie J. Hoetjes&Floris H. P. van Velden&Otto S. Hoekstra&Corneline J. Hoekstra&Nanda C. Krak&Adriaan A. Lammertsma&Ronald Boellaard. Partial volume correction strategies for quantitativeFDG PET in oncology. Eur J Nucl Med Mol Imaging 2010; 37:1679-1687.
DOI
|
16 |
Graham MM, Peterson LM, Hayward RM. Comparison ofsimplified quantitative analyses of FDG uptake. Nucl Med Biol. 2000;27(7):647-55.
DOI
|